Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Short term Debt (2019 - 2025)

Viemed Healthcare (VMD) has disclosed Short term Debt for 6 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short term Debt rose 166.5% year-over-year to $1.1 million, compared with a TTM value of $1.1 million through Dec 2025, up 166.5%, and an annual FY2025 reading of $1.1 million, up 166.5% over the prior year.
  • Short term Debt was $1.1 million for Q4 2025 at Viemed Healthcare, down from $1.6 million in the prior quarter.
  • Across five years, Short term Debt topped out at $3.2 million in Q2 2023 and bottomed at $165000.0 in Q3 2022.
  • Average Short term Debt over 5 years is $1.2 million, with a median of $1.1 million recorded in 2022.
  • The sharpest move saw Short term Debt tumbled 91.34% in 2022, then surged 1011.52% in 2023.
  • Year by year, Short term Debt stood at $1.5 million in 2021, then crashed by 88.85% to $165000.0 in 2022, then skyrocketed by 549.7% to $1.1 million in 2023, then crashed by 61.85% to $409000.0 in 2024, then surged by 166.5% to $1.1 million in 2025.
  • Business Quant data shows Short term Debt for VMD at $1.1 million in Q4 2025, $1.6 million in Q3 2025, and $820000.0 in Q2 2025.